Distinguished in WT1-Related Wilms Tumor Syndromes

Dr. Joshua M. Lang

Oncology
UW Health
University Of Wisconsin Medical Foundation Inc
705 S University Ave, Suite 200, 
Beaver Dam, WI 
Accepting New Patients
Offers Telehealth

Distinguished in WT1-Related Wilms Tumor Syndromes
UW Health
University Of Wisconsin Medical Foundation Inc
705 S University Ave, Suite 200, 
Beaver Dam, WI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Joshua Lang is an Oncologist in Beaver Dam, Wisconsin. Dr. Lang is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Nasopharyngeal Carcinoma, Familial Prostate Cancer, Prostatectomy, and Nephrectomy. Dr. Lang is currently accepting new patients.

His clinical research consists of co-authoring 109 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Licenses
Internal Medicine in WI
Hospital Affiliations
University Of Wi Hospitals & Clinics Authority
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health
  • HMO
  • POS
Cigna
  • EPO
  • HMO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Quartz
  • HMO
  • POS
  • PPO
Quartz Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Security Health
  • EPO
  • HMO
  • INDEMNITY
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

UNIVERSITY OF WISCONSIN MEDICAL FOUNDATION INC
705 S University Ave, Suite 200, Beaver Dam, WI 53916
Call: 920-887-9272
Other Locations
UNIVERSITY OF WISCONSIN MEDICAL FOUNDATION INC
600 Highland Ave, Madison, WI 53792
Call: 608-263-6400
UNIVERSITY OF WISCONSIN MEDICAL FOUNDATION INC
1 S Park St, Madison, WI 53715
Call: 608-287-2000
UNIVERSITY OF WISCONSIN MEDICAL FOUNDATION INC
5543 E Cheryl Pkwy, Fitchburg, WI 53711
Call: 608-274-5300
UNIVERSITY OF WISCONSIN MEDICAL FOUNDATION INC
100 N Nine Mound Rd, Verona, WI 53593
Call: 608-287-2770

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Other, Procedure
A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Sensitive Prostate Cancer
A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: March 19, 2025
Intervention Type: Drug
Study Drugs: TAK-700, Bicalutamide
Study Phase: Phase 3
PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer
PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer
Enrollment Status: Completed
Publish Date: December 12, 2024
Intervention Type: Drug
Study Drug: 18F DCFPyL
Study Phase: Early Phase 1
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Enrollment Status: Completed
Publish Date: September 01, 2022
Intervention Type: Other
A Phase IB Open-label, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK525762 in Combination With Androgen Deprivation Therapy and Other Agents in Subjects With Castrate-resistant Prostate Cancer (CRPC)
A Phase IB Open-label, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK525762 in Combination With Androgen Deprivation Therapy and Other Agents in Subjects With Castrate-resistant Prostate Cancer (CRPC)
Enrollment Status: Terminated
Publish Date: August 10, 2022
Intervention Type: Drug
Study Drugs: GSK525762, Abiraterone, Enzalutamide, Prednisone
Study Phase: Phase 1
A Phase 1/2a Study to Evaluate the Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine in Adult Patients With Selected Solid Tumors
A Phase 1/2a Study to Evaluate the Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine in Adult Patients With Selected Solid Tumors
Enrollment Status: Completed
Publish Date: April 19, 2022
Intervention Type: Drug, Biological
Study Drugs: GEN-009 Adjuvant Vaccine, Nivolumab, Pembrolizumab
Study Phase: Phase 1/Phase 2
View 5 Less Clinical Trials

109 Total Publications

Lossless Altered Histone Modification Analysis System (LAHMAS).
Lossless Altered Histone Modification Analysis System (LAHMAS).
Journal: Lab on a chip
Published: July 07, 2025
View All 109 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Douglas G. Mcneel
Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Douglas G. Mcneel
Oncology

University Of Wisconsin Medical Foundation Inc

600 Highland Ave, 
Madison, WI 
 (39.9 miles away)
608-263-6400
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients

Douglas Mcneel is an Oncologist in Madison, Wisconsin. Dr. Mcneel is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Adult Soft Tissue Sarcoma, and Familial Prostate Cancer. Dr. Mcneel is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Christos E. Kyriakopoulos
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Christos E. Kyriakopoulos
Hematology Oncology | Hematology | Oncology

University Of Wisconsin Medical Foundation Inc

250 Doctors Ct, 
Johnson Creek, WI 
 (25.8 miles away)
920-699-3500
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Christos Kyriakopoulos is a Hematologist Oncology specialist and a Hematologist in Johnson Creek, Wisconsin. Dr. Kyriakopoulos is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy. Dr. Kyriakopoulos is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Shahid Shekhani
Oncology | Hematology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Shahid Shekhani
Oncology | Hematology

Mercy Health System Corporation

N2950 State Rd, Suite 67, 
Lake Geneva, WI 
 (60.5 miles away)
262-245-0535
Languages Spoken:
English, Hindi, Punjabi, Urdu
See accepted insurances
Offers Telehealth

Shahid Shekhani is an Oncologist and a Hematologist in Lake Geneva, Wisconsin. Dr. Shekhani is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Lynch Syndrome, and Colorectal Cancer.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lang's expertise for a condition
ConditionClose
  • Elite
  • Prostate Cancer
    Dr. Lang is
    Elite
    . Learn about Prostate Cancer.
    See more Prostate Cancer experts
  • Distinguished
  • Adult Soft Tissue Sarcoma
    Dr. Lang is
    Distinguished
    . Learn about Adult Soft Tissue Sarcoma.
    See more Adult Soft Tissue Sarcoma experts
  • Cervical Cancer
    Dr. Lang is
    Distinguished
    . Learn about Cervical Cancer.
    See more Cervical Cancer experts
  • Chromophobe Renal Cell Carcinoma
    Dr. Lang is
    Distinguished
    . Learn about Chromophobe Renal Cell Carcinoma.
    See more Chromophobe Renal Cell Carcinoma experts
  • Familial Prostate Cancer
    Dr. Lang is
    Distinguished
    . Learn about Familial Prostate Cancer.
    See more Familial Prostate Cancer experts
  • Nasopharyngeal Carcinoma
    Dr. Lang is
    Distinguished
    . Learn about Nasopharyngeal Carcinoma.
    See more Nasopharyngeal Carcinoma experts
  • Renal Cell Carcinoma (RCC)
    Dr. Lang is
    Distinguished
    . Learn about Renal Cell Carcinoma (RCC).
    See more Renal Cell Carcinoma (RCC) experts
View All 7 Distinguished Conditions
  • Advanced
  • Clear Cell Sarcoma
    Dr. Lang is
    Advanced
    . Learn about Clear Cell Sarcoma.
    See more Clear Cell Sarcoma experts
  • Esophageal Cancer
    Dr. Lang is
    Advanced
    . Learn about Esophageal Cancer.
    See more Esophageal Cancer experts
  • Familial Colorectal Cancer
    Dr. Lang is
    Advanced
    . Learn about Familial Colorectal Cancer.
    See more Familial Colorectal Cancer experts
  • Familial Wilms Tumor 2
    Dr. Lang is
    Advanced
    . Learn about Familial Wilms Tumor 2.
    See more Familial Wilms Tumor 2 experts
  • Gastroesophageal Junction Cancer
    Dr. Lang is
    Advanced
    . Learn about Gastroesophageal Junction Cancer.
    See more Gastroesophageal Junction Cancer experts
  • Lung Cancer
    Dr. Lang is
    Advanced
    . Learn about Lung Cancer.
    See more Lung Cancer experts
View All 8 Advanced Conditions
  • Experienced
  • Bladder Cancer
    Dr. Lang is
    Experienced
    . Learn about Bladder Cancer.
    See more Bladder Cancer experts
  • Bone Tumor
    Dr. Lang is
    Experienced
    . Learn about Bone Tumor.
    See more Bone Tumor experts
  • Breast Cancer
    Dr. Lang is
    Experienced
    . Learn about Breast Cancer.
    See more Breast Cancer experts
  • Colorectal Cancer
    Dr. Lang is
    Experienced
    . Learn about Colorectal Cancer.
    See more Colorectal Cancer experts
  • Glioma
    Dr. Lang is
    Experienced
    . Learn about Glioma.
    See more Glioma experts
  • Gliomatosis Cerebri
    Dr. Lang is
    Experienced
    . Learn about Gliomatosis Cerebri.
    See more Gliomatosis Cerebri experts
View All 14 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved